BioCardia/ US09060U5074 /
| 2024-05-22 9:45:09 PM | Chg. - | Volume | Bid4:57:26 PM | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 0.31USD | - | 2,605 Turnover: 909.35 |
0.33Bid Size: 100 | -Ask Size: - | 0.36 | 0.31 |
GlobeNewswire
05-09
BioCardia to Host Q1 2024 Financial Results and Corporate Update Conference Call on May 14, 2024
GlobeNewswire
05-01
BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in...
GlobeNewswire
04-25
BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Isch...
GlobeNewswire
03-27
BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results
GlobeNewswire
03-20
BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024
GlobeNewswire
03-12
BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart ...
GlobeNewswire
03-04
BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial,...
GlobeNewswire
02-08
BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved ...
GlobeNewswire
01-03
BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for Share...
GlobeNewswire
2023-12-19
BioCardia Doses First Patient in CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchym...
GlobeNewswire
2023-12-18
BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical ...
GlobeNewswire
2023-11-29
BioCardia Shares Update from Japan PMDA Consultation on CardiAMP Autologous Cell Therapy for Ischemi...
GlobeNewswire
2023-11-16
BioCardia Announces $1.3 Million Registered Direct Offering of Common Stock Priced At-the-Market und...
GlobeNewswire
2023-11-14
BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy f...
GlobeNewswire
2023-11-08
BioCardia Reports Third Quarter 2023 Business Highlights and Financial Results
GlobeNewswire
2023-11-01
BioCardia to Host Q3 2023 Corporate Update and Financial Results Conference Call on November 8, 2023
GlobeNewswire
2023-10-11
BioCardia Announces Completion of Enrollment in Phase III CardiAMP HF Trial and Plans for CardiAMP H...
GlobeNewswire
2023-09-06
BioCardia Announces Clarification and Next Steps on its Autologous CardiAMP Cell Therapy Programs
GlobeNewswire
2023-09-05
BioCardia Announces Interim Efficacy Results in Phase III Pivotal CardiAMP Cell Therapy Heart Failur...
GlobeNewswire
2022-03-24
BioCardia to Host 2021 Financial Results and Corporate Update Conference Call on March 29, 2022
